A Study of Apatinib Combined With S1 in Patients With Advanced Gastric Cancer

Summary

Antiangiogenesis therapy plays an important role in cancer treatment. Apatinib showed good safety and efficacy as third-line therapy for advanced gastric cancer.We conducted this trial to investigate the safety and efficacy of apatinib combined with S1 after failure of first-line chemotherapy in advanced gastric cancer or gastroesophageal junction carcinoma patients.

Timeline

Start

2016-02-01

Primary completion

2018-07-31

Completion

2019-01-31

Drugs

Indications